Yetgin, S. Et Al. 2003. Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up. LEUKEMIA , vol.17, no.2 , 328-333.

Yetgin, S., Tuncer, M., Cetin, M., Gumruk, F., Yenicesu, I., Tunc, B., ... Oner, A.(2003). Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up. LEUKEMIA , vol.17, no.2, 328-333.

Yetgin, SEVGİ Et Al. "Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up," LEUKEMIA , vol.17, no.2, 328-333, 2003

Yetgin, SEVGİ Et Al. "Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up." LEUKEMIA , vol.17, no.2, pp.328-333, 2003

Yetgin, S. Et Al. (2003) . "Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up." LEUKEMIA , vol.17, no.2, pp.328-333.

@article{article, author={SEVGİ YETGİN Et Al. }, title={Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up}, journal={LEUKEMIA}, year=2003, pages={328-333} }